J.P. Morgan Notebook Day 2: Bourla Feels Pfizer's Underappreciated, GSK Prepares For Myeloma First And More

 
• By Mandy Jackson, Andrew McConaghie, and Jessica Merrill
  
Alamo Square, San Fransisco, CA
Highlights from Day 2 at J.P. Morgan. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Agency Leadership

More from Pink Sheet